Demulder A, Suggs S V, Zsebo K M, Scarcez T, Roodman G D
Veterans Administration Hospital, San Antonio, Texas.
J Bone Miner Res. 1992 Nov;7(11):1337-44. doi: 10.1002/jbmr.5650071114.
Stem cell factor (SCF) is a newly described hematopoietic growth factor that stimulates the growth of primitive hematopoietic progenitors and mast cells. Since the osteoclast precursor is hematopoietic in origin, we tested SCF for its capacity to stimulate the formation of osteoclast-like multinucleated cells (MNC) in long-term human marrow cultures. These MNC express an osteoclast phenotype and form resorption lacunae on calcified matrices. Addition of SCF alone (0.1 pg/ml to 100 ng/ml) to long-term marrow cultures did not increase MNC formation. However, treatment of these cultures sequentially with SCF for 1 week followed by 1,25-(OH)2D3 for the second and third weeks of culture significantly enhanced MNC formation. [3H]Thymidine incorporation studies showed that SCF increased the proliferation of MNC precursors. These data suggested that SCF was acting on early MNC precursors. We then tested the capacity of SCF to stimulate the formation of colonies of committed precursors for osteoclast-like MNC. SCF (20 pg/ml to 20 ng/ml) enhanced osteoclast precursor formation in unfractionated bone marrow mononuclear cells but was unable to increase osteoclast precursor formation when a highly purified population of hematopoietic precursors was used as the target cells for SCF. These data suggest that SCF works in concert with other factors produced by nonhematopoietic marrow cells to increase the precursor pool for osteoclasts and that other factors, such as 1,25-(OH)2D3, complete the differentiation process to the mature osteoclast.
干细胞因子(SCF)是一种新描述的造血生长因子,可刺激原始造血祖细胞和肥大细胞的生长。由于破骨细胞前体起源于造血系统,我们检测了SCF在长期人类骨髓培养中刺激破骨细胞样多核细胞(MNC)形成的能力。这些MNC表达破骨细胞表型,并在钙化基质上形成吸收陷窝。单独向长期骨髓培养物中添加SCF(0.1 pg/ml至100 ng/ml)不会增加MNC的形成。然而,在培养的第二周和第三周,先用SCF处理这些培养物1周,然后用1,25-(OH)2D3处理,可显著增强MNC的形成。[3H]胸苷掺入研究表明,SCF增加了MNC前体的增殖。这些数据表明SCF作用于早期MNC前体。然后,我们检测了SCF刺激破骨细胞样MNC定向前体集落形成的能力。SCF(20 pg/ml至20 ng/ml)可增强未分级骨髓单个核细胞中破骨细胞前体的形成,但当使用高度纯化的造血前体细胞群体作为SCF的靶细胞时,无法增加破骨细胞前体的形成。这些数据表明,SCF与非造血骨髓细胞产生的其他因子协同作用,以增加破骨细胞的前体池,而其他因子,如1,25-(OH)2D3,则完成向成熟破骨细胞的分化过程。